¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2023 Spring Semi-Annual Meeting 1ÀÏÂ÷ : 2023-05-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2023 Spring Semi-Annual Meeting 1ÀÏÂ÷ : 2023-05-19
±³À°ÀÏÀÚ : 2023-05-19
±³À°Àå¼Ò : ¿©¼ö¾×½ºÆ÷ÄÁº¥¼Ç

±³À°ÁÖÁ¦ : KGOG 2023 Spring Semi-Annual Meeting 1ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸

´ã´çÀÚ : ±èÀμ÷
¿¬¶ôó : 02-512-5420

À̸ÞÀÏ : kiskgog@hanmail.net

±³À°Á¾·ù : »êºÎÀΰú, ¹æ»ç¼±Á¾¾çÇаú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 3 ½Ã°£ 56ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 13:00~13:15 Current status, protocol amendments, and a dummy-run evaluation À§Âù¿ì(º¸¶ó¸Åº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 13:15~13:30 RT-QA for SABR-ROC ±èÈ£Áø(¿¬¼¼¾Ïº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 13:30~13:45 Practical issues of RT simulation and planning ±è¼¼¿µ(¿¬¼¼¾Ïº´¿ø)

Åä·Ð 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 13:45~13:55 Discussion ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 14:00~14:05 KGOG1047/Debulk Protocol update ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 14:10~14:25 E-CRF opening and demonstration ÇÑ°æÈñ(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 14:25~14:40 Registration Cases and Practical Difficulties ±è´ë¿¬(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 14:40~14:50 Spatiotemporal genomics in cancer ÀÌÁø±¸(¼­¿ïÀÇ´ë)

Åä·Ð 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 14:50~15:00 Discussion ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 15:00~15:03 Cervix, Vulva, Vagina Committee-introduction À̱ÙÈ£(¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 15:03~15:13 Review of study of cervical cancer in GOG 2023-NRG winter 2023 Á¤¿ë¿í(°­³²Â÷º´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 15:13~15:23 Review of study of cervical cancer in GOG 2023-SGO 2023 À̼ºÁ¾(¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 15:23~15:38 Brainstorming session 3-1. Clinical trials in preinvasive CIN ±è¹ÎÁ¤(ÀÏ»êÂ÷º´¿ø)

Åä·Ð 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 15:38~15:43 discussion ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 15:43~15:58 Brainstorming session 3-1. Clinical trialos in vulva, vagina °øÅ¿í(¾ÆÁִ뺴¿ø)

Åä·Ð 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 15:58~16:01 discussion ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 16:01~16:16 Review of protocol-Debulk, selpax, after ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 17:00~17:15 The Eolution of Endometrial Cancers: Biomarkers and Clinical Decision Making Á¤¹ÎÇü(°æÈñ´ëº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 17:15~17:30 Transforming Outcomes: Endometrial Cancer and Dostarlimab Á¶ÇѺ°(°­³²¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 17:30~17:45 Impact of MLH1 mutation vs. hypermethylation on response to PD-1 antibody Odette Allonby(GSK Global Scientific Director)

Åä·Ð 05¿ù 19ÀÏ ÄÁÆÛ·±½ºÈ¦ 17:45~17:50 discussion ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2023 Spring Semi-Annual Meeting 1ÀÏÂ÷ : 2023-05-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦39Â÷ ÀÇÇб³À°Çмú´ëȸ(2ÀÏÂ÷) : 2023-05-19
´ÙÀ½±Û 2023 KMDS ½Å°æ°ú Àǻ縦 À§ÇÑ º¸ÇàºÐ¼® ¿öÅ©¼¥ (4ȸ) : 2023-05-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 26 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 46 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷